Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Prevention – December 2009

To see all of this brand's ads on AdPharm, click here

Ezetimibe/simvastatin is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe reduces blood cholesterol by inhibiting absorption of cholesterol by the small intestine by acting at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009

To see all of this brand’s ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on image to view the commercial

Activia® contains a unique strain of bifidobacteria, called Bifidobacterium (animalis) lactis, or BL Regularis.

More on Activia.ca

Agency: Saint-Jacques Vallée Young & Rubicam
Creative Director: Daniel Poirier
Creative Team: Annie Chevalier, Maxime Richer, Donald Samson, Martin Snape
Agency Producer: Véronique Novi
Director: Charles Éric Savard
Production House: Jet Films
Producer: Geneviève Sylvestre
Audio: Sonart

Brand name: Activia
Company: Danone
Country/Market: Canada, North America
Indication(s)/use: Nutrition
Target: Consumers (DTC)
Publication: 2009

Today, I took steps to balance my type 2 diabetes.
Today, I chose salad and talked to my doctor.

It’s time. Crestor

Call 1-888-JANUVIA or visit Januvia.com

A different way. Januvia.

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only 2nd Generation DPP4 inhibitor currently available. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) is an alternative drug that also works with the incretin system. – Wikipedia

US News and World Report February 2009

Click on images to view the tv commercials and the print ad.

ColonCancerCheck.ca
Paid for by the Government of Ontario

Agency: BBDO Toronto
Executive Creative Director: Ian MacKellar
Co-Creative Director: Peter Ignazi
Co-Creative Director: Carlos Moreno
Copywriter: Craig McIntosh
Art Director: Jaimes Zentil
Art Director: Kevin Filliter
Creative Design Director: Jon Tisdall
Freelance Producer: Sharon Kosowkosk

Anatomical and Cancer Awareness ads on AdPharm